Your browser doesn't support javascript.
loading
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC.
Del Re, Marzia; Marconcini, Riccardo; Pasquini, Giulia; Rofi, Eleonora; Vivaldi, Caterina; Bloise, Francesco; Restante, Giuliana; Arrigoni, Elena; Caparello, Chiara; Bianco, Maria Grazia; Crucitta, Stefania; Petrini, Iacopo; Vasile, Enrico; Falcone, Alfredo; Danesi, Romano.
Afiliación
  • Del Re M; Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Marconcini R; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Pasquini G; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Rofi E; Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Vivaldi C; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Bloise F; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Restante G; Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Arrigoni E; Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Caparello C; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Bianco MG; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Crucitta S; Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Petrini I; General pathology, Department of Translational Research and New Technologies in Surgery and Medicine, University of Pisa, Pisa, Italy.
  • Vasile E; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Falcone A; Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Danesi R; Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Br J Cancer ; 118(6): 820-824, 2018 03 20.
Article en En | MEDLINE | ID: mdl-29509748
ABSTRACT
This corrects the article DOI 10.1038/bjc.2017.85.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: ARN Mensajero / Exosomas / Receptor de Muerte Celular Programada 1 Tipo de estudio: Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: ARN Mensajero / Exosomas / Receptor de Muerte Celular Programada 1 Tipo de estudio: Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2018 Tipo del documento: Article País de afiliación: Italia